ID   OXLAB_CERCE             Reviewed;         172 AA.
AC   P0DQH9;
DT   16-OCT-2019, integrated into UniProtKB/Swiss-Prot.
DT   16-OCT-2019, sequence version 1.
DT   07-APR-2021, entry version 4.
DE   RecName: Full=L-amino acid oxidase {ECO:0000303|PubMed:30647580};
DE   AltName: Full=CC-LAAO {ECO:0000303|PubMed:30647580};
DE            Short=LAO;
DE            EC=1.4.3.2 {ECO:0000269|PubMed:30647580};
DE   Flags: Fragments;
OS   Cerastes cerastes (Horned desert viper).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata; Toxicofera;
OC   Serpentes; Colubroidea; Viperidae; Viperinae; Cerastes.
OX   NCBI_TaxID=8697;
RN   [1]
RP   PROTEIN SEQUENCE, FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION,
RP   BIOPHYSICOCHEMICAL PROPERTIES, SUBCELLULAR LOCATION, AND SUBSTRATE
RP   SPECIFICITY.
RC   TISSUE=Venom;
RX   PubMed=30647580; DOI=10.1016/j.jgeb.2015.09.003;
RA   El Hakim A.E., Salama W.H., Hamed M.B., Ali A.A., Ibrahim N.M.;
RT   "Heterodimeric l-amino acid oxidase enzymes from Egyptian Cerastes cerastes
RT   venom: Purification, biochemical characterization and partial amino acid
RT   sequencing.";
RL   J. Genet. Eng. Biotechnol. 13:165-176(2015).
CC   -!- FUNCTION: Catalyzes an oxidative deamination of predominantly
CC       hydrophobic and aromatic L-amino acids, thus producing hydrogen
CC       peroxide that may contribute to the diverse toxic effects of this
CC       enzyme (PubMed:30647580). Shows high specificity for L-Arg, L-Met, L-
CC       Phe, L-Leu, L-Tyr, L-Ile and L-Trp, low specificity for L-Val, L-Ala,
CC       L-Asn, L-Gln, and no specificity for L-Pro, L-Ser, L-Thr, L-Cys, L-Gly
CC       and L-Asp (PubMed:30647580). Exhibits diverse biological activities,
CC       such as hemorrhage, hemolysis, edema, antibacterial and antiparasitic
CC       activities, as well as regulation of platelet aggregation. Its effect
CC       on platelets is controversial, since it either induces aggregation or
CC       inhibits agonist-induced aggregation. These different effects are
CC       probably due to different experimental conditions. {ECO:0000250,
CC       ECO:0000269|PubMed:30647580}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an L-alpha-amino acid + H2O + O2 = a 2-oxocarboxylate + H2O2 +
CC         NH4(+); Xref=Rhea:RHEA:13781, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:28938, ChEBI:CHEBI:35179,
CC         ChEBI:CHEBI:59869; EC=1.4.3.2;
CC         Evidence={ECO:0000269|PubMed:30647580};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-leucine + O2 = 4-methyl-2-oxopentanoate + H2O2 +
CC         NH4(+); Xref=Rhea:RHEA:60996, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:17865, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:57427; Evidence={ECO:0000269|PubMed:30647580};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-phenylalanine + O2 = 3-phenylpyruvate + H2O2 + NH4(+);
CC         Xref=Rhea:RHEA:61240, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:18005, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:58095; Evidence={ECO:0000269|PubMed:30647580};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-tryptophan + O2 = H2O2 + indole-3-pyruvate + NH4(+);
CC         Xref=Rhea:RHEA:61244, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:17640, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:57912; Evidence={ECO:0000269|PubMed:30647580};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-methionine + O2 = 4-methylsulfanyl-2-oxobutanoate +
CC         H2O2 + NH4(+); Xref=Rhea:RHEA:61236, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:16723,
CC         ChEBI:CHEBI:28938, ChEBI:CHEBI:57844;
CC         Evidence={ECO:0000269|PubMed:30647580};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-isoleucine + O2 = (S)-3-methyl-2-oxopentanoate + H2O2
CC         + NH4(+); Xref=Rhea:RHEA:61232, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:28938, ChEBI:CHEBI:35146,
CC         ChEBI:CHEBI:58045; Evidence={ECO:0000269|PubMed:30647580};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-arginine + O2 = 5-guanidino-2-oxopentanoate + H2O2 +
CC         NH4(+); Xref=Rhea:RHEA:51404, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:28938, ChEBI:CHEBI:32682,
CC         ChEBI:CHEBI:58489; Evidence={ECO:0000269|PubMed:30647580};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-tyrosine + O2 = 3-(4-hydroxyphenyl)pyruvate + H2O2 +
CC         NH4(+); Xref=Rhea:RHEA:61248, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:28938, ChEBI:CHEBI:36242,
CC         ChEBI:CHEBI:58315; Evidence={ECO:0000269|PubMed:30647580};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000250|UniProtKB:P81382};
CC   -!- ACTIVITY REGULATION: Activity is increased by Mn(2+) ions. Inhibited by
CC       Zn(2+), Ni(2+), Co(2+), Cu(2+) and Al(3+). No significant activity
CC       change by Na(+), K(+), Ca(2+), Mg(2+) and Ba(2+) ions. Both isoform are
CC       completely inhibited by L-Cys and reduced glutathione. O-
CC       phenanthroline, beta-mercaptoethanol and PMSF completely inhibit the
CC       enzymatic activity of LAAOII, but have no activity on LAAOI. Iodoacitic
CC       acid inhibits the enzymatic activity of LAAOII by 46% but has no effect
CC       on the LAAOI activity. {ECO:0000269|PubMed:30647580}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.67 mM for L-Leu (Cc-LAAOI isoform)
CC         {ECO:0000269|PubMed:30647580};
CC         KM=0.82 mM for L-Leu (Cc-LAAOII isoform)
CC         {ECO:0000269|PubMed:30647580};
CC       pH dependence:
CC         Optimum pH is 7.8 (Cc-LAAOI) and 7 (Cc-LAAOII).
CC         {ECO:0000269|PubMed:30647580};
CC       Temperature dependence:
CC         Optimum temperature is 50 (Cc-LAAOI) and 60 (Cc-LAAOII) degrees
CC         Celsius. {ECO:0000269|PubMed:30647580};
CC   -!- SUBUNIT: Heterodimer; non-covalently linked.
CC       {ECO:0000305|PubMed:30647580}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:30647580}.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC       {ECO:0000305|PubMed:30647580}.
CC   -!- PTM: N-glycosylated. {ECO:0000250|UniProtKB:P81382}.
CC   -!- SIMILARITY: Belongs to the flavin monoamine oxidase family. FIG1
CC       subfamily. {ECO:0000305}.
CC   -!- CAUTION: Two L-amino-acid oxidase isoforms from C.cerastes venom have
CC       been described: Cc-LAAOI and Cc-LAAOII. Both isoforms show very similar
CC       activities on different substrates tested, as well as for activity
CC       regulation by metal ions. It is unknown which isoform is presented
CC       here. {ECO:0000269|PubMed:30647580}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   SMR; P0DQH9; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0106329; F:L-phenylalaine oxidase activity; IEA:RHEA.
DR   GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR   GO; GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW.
DR   GO; GO:0044179; P:hemolysis in other organism; IEA:UniProtKB-KW.
PE   1: Evidence at protein level;
KW   Antibiotic; Antimicrobial; Cytolysis; Direct protein sequencing;
KW   Disulfide bond; FAD; Flavoprotein; Glycoprotein; Hemolysis;
KW   Hemostasis impairing toxin; Oxidoreductase;
KW   Platelet aggregation inhibiting toxin; Secreted; Toxin.
FT   CHAIN           1..>172
FT                   /note="L-amino acid oxidase"
FT                   /id="PRO_0000448257"
FT   NP_BIND         44..47
FT                   /note="FAD"
FT                   /evidence="ECO:0000250|UniProtKB:P81382"
FT   BINDING         47
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P81382"
FT   BINDING         103
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P81382"
FT   DISULFID        10..?
FT                   /evidence="ECO:0000250|UniProtKB:P81382"
FT   NON_CONS        24..25
FT                   /evidence="ECO:0000303|PubMed:30647580"
FT   NON_CONS        33..34
FT                   /evidence="ECO:0000303|PubMed:30647580"
FT   NON_CONS        51..52
FT                   /evidence="ECO:0000303|PubMed:30647580"
FT   NON_CONS        67..68
FT                   /evidence="ECO:0000303|PubMed:30647580"
FT   NON_CONS        89..90
FT                   /evidence="ECO:0000303|PubMed:30647580"
FT   NON_CONS        102..103
FT                   /evidence="ECO:0000303|PubMed:30647580"
FT   NON_CONS        133..134
FT                   /evidence="ECO:0000303|PubMed:30647580"
FT   NON_CONS        145..146
FT                   /evidence="ECO:0000303|PubMed:30647580"
FT   NON_TER         172
FT                   /evidence="ECO:0000303|PubMed:30647580"
SQ   SEQUENCE   172 AA;  19921 MW;  9AC75A4391D4DD5C CRC64;
     ADDKNPLEEC FREADYEEFL EIAKVTVLEA SERNDKEDWY ANLGPMRLPE KLNEFVQETE
     NGWYFIKYPV KPSEEGKSAG QLYEESLRKS AGQLYQESLG KAHDDIFAYE KRFDEIVDGM
     DKLPTSMYQA IQERINFKPP LPPKKYAMGA ITTFTPYQFQ HFSEALTAPV GR
//
